PL1660532T3 - Polipeptydy fuzyjne i ich zastosowanie w przeciwnaczyniowej terapii guzów nowotworowych - Google Patents

Polipeptydy fuzyjne i ich zastosowanie w przeciwnaczyniowej terapii guzów nowotworowych

Info

Publication number
PL1660532T3
PL1660532T3 PL04764346T PL04764346T PL1660532T3 PL 1660532 T3 PL1660532 T3 PL 1660532T3 PL 04764346 T PL04764346 T PL 04764346T PL 04764346 T PL04764346 T PL 04764346T PL 1660532 T3 PL1660532 T3 PL 1660532T3
Authority
PL
Poland
Prior art keywords
fusion polypeptides
tumor therapy
antivascular
antivascular tumor
therapy
Prior art date
Application number
PL04764346T
Other languages
English (en)
Inventor
Wolfgang E Berdel
Rolf M Mesters
Original Assignee
Berdel Wolfgang
Oncoscience Ag
Bizimis Ari E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berdel Wolfgang, Oncoscience Ag, Bizimis Ari E filed Critical Berdel Wolfgang
Publication of PL1660532T3 publication Critical patent/PL1660532T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL04764346T 2003-08-22 2004-08-20 Polipeptydy fuzyjne i ich zastosowanie w przeciwnaczyniowej terapii guzów nowotworowych PL1660532T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10338733A DE10338733A1 (de) 2003-08-22 2003-08-22 Fusionspolypeptide und deren Verwendung für die antivaskuläre Tumortherapie
PCT/EP2004/009364 WO2005021593A1 (de) 2003-08-22 2004-08-20 Fusionspolypeptide und deren verwendung für die antivaskuläre tumortherapie
EP04764346A EP1660532B1 (de) 2003-08-22 2004-08-20 Fusionspolypeptide und deren verwendung für die antivaskuläre tumortherapie

Publications (1)

Publication Number Publication Date
PL1660532T3 true PL1660532T3 (pl) 2013-03-29

Family

ID=34201891

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04764346T PL1660532T3 (pl) 2003-08-22 2004-08-20 Polipeptydy fuzyjne i ich zastosowanie w przeciwnaczyniowej terapii guzów nowotworowych

Country Status (13)

Country Link
US (1) US7618943B2 (pl)
EP (1) EP1660532B1 (pl)
JP (1) JP5149506B2 (pl)
CN (1) CN1871258B (pl)
AU (1) AU2004268031B2 (pl)
CA (1) CA2535856C (pl)
DE (1) DE10338733A1 (pl)
DK (1) DK1660532T3 (pl)
ES (1) ES2397922T3 (pl)
PL (1) PL1660532T3 (pl)
PT (1) PT1660532E (pl)
SI (1) SI1660532T1 (pl)
WO (1) WO2005021593A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2097517B1 (en) 2006-10-16 2014-06-04 Genelux Corporation Recombinant Lister strain vaccinia virus encoding an anti-VEGF single chain antibody
KR100879239B1 (ko) * 2007-04-19 2009-01-16 (주)케어젠 Ｔｇｆｐ－ｃａｐ 펩타이드 및 그의 용도
CN102153653B (zh) * 2010-12-30 2012-08-15 厦门大学 肿瘤血管靶向多肽与组织因子的融合蛋白及其制备方法
IN2015KN00571A (pl) 2012-08-13 2015-07-17 Otago Innovation Ltd
CN104387474B (zh) * 2014-11-17 2018-01-23 北京华安科创生物技术有限公司 一种肿瘤血管梗塞剂多肽、基因、表达载体及其应用
EP3960177A1 (en) * 2020-08-26 2022-03-02 Anturec Pharmaceuticals GmbH Composition comprising ttf-ngr for use in treating soft-tissue sarcoma
JP2024516402A (ja) * 2021-05-06 2024-04-15 フィブロバイオロジクス インコーポレイテッド 線維芽細胞を利用した腫瘍血管壊死の誘導
WO2024102818A1 (en) * 2022-11-09 2024-05-16 Wisconsin Alumni Research Foundation Combination tumor therapy with thrombosis initiation and platelet recruitment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093399A (en) * 1992-03-05 2000-07-25 Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of vasculature
US6004555A (en) * 1992-03-05 1999-12-21 Board Of Regents, The University Of Texas System Methods for the specific coagulation of vasculature
US5858724A (en) * 1996-07-16 1999-01-12 Pel-Freez Recombinant rabbit tissue factor
WO1998031394A2 (en) * 1997-01-22 1998-07-23 Board Of Regents, The University Of Texas System Tissue factor methods and compositions for coagulation and tumor treatment
US7067109B1 (en) * 1998-07-13 2006-06-27 Board Of Regents, The University Of Texas System Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
US7622437B2 (en) * 2000-11-20 2009-11-24 The Board Of Trustees Of The University Of Illinois Tissue factor compositions and methods
AU2002350623A1 (en) * 2001-10-26 2003-05-06 The Scripps Research Institute Targeted thrombosis by tissue factor polypeptides
US7425328B2 (en) * 2003-04-22 2008-09-16 Purdue Pharma L.P. Tissue factor antibodies and uses thereof

Also Published As

Publication number Publication date
HK1087418A1 (en) 2006-10-13
CA2535856A1 (en) 2005-03-10
CN1871258A (zh) 2006-11-29
CN1871258B (zh) 2012-05-30
SI1660532T1 (sl) 2013-02-28
ES2397922T3 (es) 2013-03-12
WO2005021593A1 (de) 2005-03-10
EP1660532B1 (de) 2012-10-24
PT1660532E (pt) 2013-01-29
AU2004268031A1 (en) 2005-03-10
CA2535856C (en) 2016-06-07
DK1660532T3 (da) 2013-01-21
US20070032419A1 (en) 2007-02-08
AU2004268031B2 (en) 2009-09-03
EP1660532A1 (de) 2006-05-31
JP2007528722A (ja) 2007-10-18
JP5149506B2 (ja) 2013-02-20
US7618943B2 (en) 2009-11-17
DE10338733A1 (de) 2005-03-24

Similar Documents

Publication Publication Date Title
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
PL374586A1 (pl) Przeciwciała bispecyficzne anty-Erb-B oraz ich zastosowanie w terapii nowotworowej
EP1572724A4 (en) KDR AND VEGF / KDR BINDING SPEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY
AU2003278807A8 (en) KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
IL166396A0 (en) Vanilloid receptor ligands and their use in treatments
GB0212885D0 (en) Therapeutic epitopes and uses thereof
AP2006003537A0 (en) Use of polypeptides of the cupredoxin family in cancer therapy.
PL379553A1 (pl) Ligandy receptora waniloidowego oraz ich zastosowanie w leczeniu
AU2003304203A8 (en) Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
IL172316A0 (en) Novel compounds and their use in therapy
AU2003215460A8 (en) Cancer associated protein kinases and their uses
ZA200703699B (en) Nitrobenzindoles and their use in cancer therapy
PL1660532T3 (pl) Polipeptydy fuzyjne i ich zastosowanie w przeciwnaczyniowej terapii guzów nowotworowych
ZA200210316B (en) Composition and its therapeutic use.
AU2003255544A8 (en) Tumor specific oligosaccharide epitopes and use thereof
GB0326578D0 (en) Cancer diagnosis and therapy
AU2003265023A8 (en) Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy
AU2003227861A8 (en) Protein involved in cancer
HRP20041037A2 (en) Binding agents and their use in targeting tumor cells
SI1639013T1 (sl) Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji
AU2003209459A8 (en) Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
IL171915A0 (en) Il-18 like polypeptides, their preparation and use
GB0224014D0 (en) A protein involved in therapy
IL173796A0 (en) Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases
IL174101A0 (en) UBP8rp POLYPEPTIDES, THEIR PREPARATION AND THEIR USE